AEC < 0.11, × 109/l (86, 42.8%) | AEC ≥ 0.11, × 109/l (115, 57.2%) | p value | |
---|---|---|---|
Age, years | 79.0 (70.25–84.25) | 76.0 (70.0–83.0) | 0.530 |
Sex, female | 49 (57.0%) | 71 (61.7%) | 0.496 |
HT | 16 (18.6%) | 7 (6.1%) | 0.006 |
sICH | 9 (10.5%) | 5 (4.3%) | 0.092 |
Time to the start of IVT, min | 160.0 (120.0–196.3) | 145.0 (110.0–180.0) | 0.048 |
Baseline NIHSS | 9.0 (5.8–16.0) | 10.0 (7.0–14.0) | 0.416 |
SBP, mmHg | 167.5 (±27.5) | 164.7 (±29.6) | 0.501 |
DBP, mmHg | 94.7 (±16.4) | 92.6 (±17.1) | 0.390 |
INR | 1.02 (0.97–1.10) | 1.02 (0.95–1.07) | 0.214 |
GFR, ml/min/1.73m2 | 61.23 (44.93–75.52) | 62.83 (52.34–73.81) | 0.594 |
Blood glucose, mmol/l | 6.59 (5.81–7.72) | 6.66 (6.02–7.73) | 0.501 |
Haemoglobin, g/l | 134.2 (±15.8) | 134.2 (±15.6) | 0.996 |
Neutrophils, × 109/l | 4.52 (3.40–6.66) | 4.55 (3.65–5.54) | 0.434 |
Lymphocytes, × 109/l | 1.61 (1.24–2.16) | 2.21 (1.72–2.91) | < 0.001 |
Monocytes, × 109/l | 0.58 (0.46–0.74) | 0.68 (0.53–0.85) | 0.003 |
NLR | 2.84 (1.75–4.80) | 1.91 (1.49–2.91) | 0.001 |
LMR | 2.76 (2.06–3.81) | 3.20 (2.61–4.82) | < 0.001 |
Platelets, × 109/l | 202.5 (171.0–244.3) | 220.0 (183.0–262.0) | 0.038 |
Diabetes mellitus | 7 (8.1%) | 28 (24.3%) | 0.003 |
Atrial fibrillation at admission | 34 (39.5%) | 41 (35.7%) | 0.573 |
Previous stroke | 8 (9.3%) | 16 (13.9%) | 0.319 |
Pre-admission anticoagulant use | 10 (11.6%) | 9 (7.8%) | 0.362 |
Pre-admission antiaggregant use | 16 (18.6%) | 20 (17.4%) | 0.824 |